Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New antitumor agents from Agouron acting as inhibitors of cyclin-dependent kinases

June 9, 1999

3-D structure of MMP-2 published

June 9, 1999

GlycoDesign seeks partners to advance the development of GlcNAc-TV enzyme inhibitors

June 9, 1999

Novel antitumor agents from Minophagen with an imidazo[1,5-a]pyrimidine structure

June 9, 1999

Pyrisulfoxins: new antibiotics isolated and tested for antileukemic activity

June 8, 1999

Bristol-Myers Squibb patents new paclitaxel-derived antitumor agents

June 8, 1999

Atrix completes phase I clinical trial for prostate cancer therapy

June 8, 1999

Cytran's IM-862 awarded antiangiogenesis patent

June 8, 1999

Photogen achieves favorable preliminary results with ocular melanoma treatment

June 8, 1999

Angiogenesis inhibitor SU-5416 poised to enter phase III testing in U.S. and Europe

June 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...